Southern Research names Mark Suto VP
This article was originally published in Scrip
Southern research Institute, a not-for-profit scientific research organisation, has appointed Dr Mark Suto vice-president of the drug discovery division. Dr Suto and his team will focus on the research and discovery of new therapies for cancer, infectious diseases and neurological diseases and disorders. Dr Suto most recently served as vice-president of chemical and pharmaceutical sciences for Icagen.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.